These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease.
    Author: Zou JJ, Zhou XT, Chen YK, Liu JL, Wang C, Ma YR, Wang L.
    Journal: Biomed Pharmacother; 2020 Dec; 132():110833. PubMed ID: 33035831.
    Abstract:
    Chronic kidney disease (CKD) is one of the most common conditions which significantly increases the risk for serious health outcomes. Epidemiological investigations have shown that CKD has become a serious global health problem. At present, there are no treatments for CKD, thus the need for an effective and safe treatment for this condition. Shenkang Injection (SKI), which is an herbal medication in Chinese Medicine, has been used in the management and treatment of CKD and has achieved favorable therapeutic effects. The purpose of this paper is to review the clinical efficacy, mechanism of action, and safety profile of SKI when used in CKD, and to provide comprehensive potential evidence for its clinical application.
    [Abstract] [Full Text] [Related] [New Search]